Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
作者信息
Monfort Pilar, Felipo Vicente
机构信息
Laboratory of Neurobiology, Fundación Valenciana de Investigaciones Biomédicas, Valencia, Spain.
出版信息
BMC Pharmacol. 2005 Jun 16;5 Suppl 1(Suppl 1):P66. doi: 10.1186/1471-2210-5-S1-P66.
Abstract
摘要
相似文献
1
Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
BMC Pharmacol. 2005 Jun 16;5 Suppl 1(Suppl 1):P66. doi: 10.1186/1471-2210-5-S1-P66.
2
Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Neurochem Int. 2004 Nov;45(6):895-901. doi: 10.1016/j.neuint.2004.03.020.
3
Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
J Neurochem. 2005 Aug;94(4):934-42. doi: 10.1111/j.1471-4159.2005.03236.x.
4
Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
Neurobiol Dis. 2004 Feb;15(1):1-10. doi: 10.1016/j.nbd.2003.09.008.
5
Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
J Neurosci. 2002 Dec 1;22(23):10116-22. doi: 10.1523/JNEUROSCI.22-23-10116.2002.
6
Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
Metab Brain Dis. 2005 Dec;20(4):265-74. doi: 10.1007/s11011-005-7905-5.
7
Cyclic GMP metabolism and its role in brain physiology.
J Physiol Pharmacol. 2005 Mar;56 Suppl 2:15-34.
8
Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade.
BMC Pharmacol. 2004 Oct 28;4:28. doi: 10.1186/1471-2210-4-28.
9
Increases of guanosine 3',5'-monophosphate-related enzymes in kidneys of developing rats.
Pediatr Res. 1978 Aug;12(8):882-5. doi: 10.1203/00006450-197808000-00017.
10
Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):48-54. doi: 10.1111/j.1440-1681.2007.04532.x.
引用本文的文献
1
Influence of the Flavonoid, Quercetin on Antioxidant Status, Lipid Peroxidation and Histopathological Changes in Hyperammonemic Rats.
Indian J Clin Biochem. 2017 Jul;32(3):275-284. doi: 10.1007/s12291-016-0603-8. Epub 2016 Aug 11.
2
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.
Pharmacol Rev. 2010 Sep;62(3):525-63. doi: 10.1124/pr.110.002907.
3
Antioxidant Potential of Momordica Charantia in Ammonium Chloride-Induced Hyperammonemic Rats.
Evid Based Complement Alternat Med. 2011;2011:612023. doi: 10.1093/ecam/nep227. Epub 2011 Jun 8.
4
Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study.
Mol Cell Biochem. 2009 Jul;327(1-2):153-61. doi: 10.1007/s11010-009-0053-1. Epub 2009 Feb 24.
Zotero 插件